Convection-enhanced delivery of SN-38-loaded polymeric micelles (NK012) enables consistent distribution of SN-38 and is effective against rodent intracranial brain tumor models

Drug Delivery
Rong ZhangTeiji Tominaga

Abstract

Convection-enhanced delivery (CED) of therapeutic agents is a promising local delivery technique that has been extensively studied as a treatment for CNS diseases over the last two decades. One continuing challenge of CED is accurate and consistent delivery of the agents to the target. The present study focused on a new type of therapeutic agent, NK012, a novel SN-38-loaded polymeric micelle. Local delivery profiles of NK012 and SN-38 were studied using rodent brain and intracranial rodent brain tumor models. First, the cytotoxicity of NK012 against glioma cell lines was determined in vitro. Proliferations of glioma cells were significantly reduced after exposure to NK012. Then, the distribution and local toxicity after CED delivery of NK012 and SN-38 were evaluated in vivo. Volume of distribution of NK012 after CED was much larger than that of SN-38. Histological examination revealed minimum brain tissue damage in rat brains after delivery of 40 µg NK012 but severe damage with SN-38 at the same dose. Subsequently, the efficacy of NK012 delivered via CED was tested in 9L and U87MG rodent orthotopic brain tumor models. CED of NK012 displayed excellent efficacy in the 9L and U87MG orthotopic brain tumor models. Furthermore, NK012...Continue Reading

References

Mar 15, 1994·Proceedings of the National Academy of Sciences of the United States of America·R H BoboE H Oldfield
May 20, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H S FriedmanL L Miller
Jun 17, 1999·Advances and Technical Standards in Neurosurgery·Y SawamuraN de Tribolet
May 9, 2002·Journal of Neuro-oncology·Marc C Chamberlain
Dec 2, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Grace H HuynhFrancis C Szoka
Mar 15, 2006·Neuro-oncology·Michael D PradosUNKNOWN North American Brain Tumor Consortium
Feb 4, 2009·International Journal of Cancer. Journal International Du Cancer·Jun-ichiro KurodaYasuhiro Matsumura
Dec 22, 2009·Journal of Neurosurgery·John H SampsonUNKNOWN PRECISE Trial Investigators
Jan 14, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jun-ichiro KurodaYasuhiro Matsumura
Jun 1, 2010·Neuro-oncology·Sandeep KunwarUNKNOWN PRECISE Study Group

❮ Previous
Next ❯

Citations

Aug 14, 2018·Journal of Drug Targeting·Feng YuYanyu Xiao
Nov 20, 2018·Nanomedicine·Fatemeh FarjadianMichael R Hamblin
Dec 17, 2020·Pharmaceutics·Jessica I GriffithWilliam F Elmquist
Oct 9, 2020·Advanced Drug Delivery Reviews·Aroa Duro-CastanoGiuseppe Battaglia
Apr 14, 2019·Trends in Pharmacological Sciences·Hélène LajousEmmanuel Garcion

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.